fructose-1,6-diphosphate and Lung Injury, Acute

fructose-1,6-diphosphate has been researched along with Lung Injury, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, FL; Gong, Q; Hu, LY; Jin, XB; Yang, H; Yin, H; Zhu, JY1
Alves, SH; Bartrons, R; de Mello, RO; de Oliveira, JR; Kober, H; Mário, DN; Moresco, RN; Peña Rico, MA; Rosa, JL; Santos, RC; Scherer, P; Susperregui, AR; Tatsch, E; Ventura, F1

Other Studies

2 other study(ies) available for fructose-1,6-diphosphate and Lung Injury, Acute

ArticleYear
Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice.
    International immunopharmacology, 2008, Dec-20, Volume: 8, Issue:13-14

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Disease Models, Animal; Fructosediphosphates; Interleukin-6; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred BALB C; NF-kappaB-Inducing Kinase; Nitric Oxide Synthase Type II; Peroxidase; Protein Serine-Threonine Kinases; Signal Transduction; Tumor Necrosis Factor-alpha

2008
Fructose-1,6-bisphosphate protects against Zymosan-induced acute lung injury in mice.
    Inflammation, 2012, Volume: 35, Issue:3

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Cyclooxygenase 2; Edema; Fructosediphosphates; Inflammation; Interleukin-6; Lung; Macrophages; Male; Mice; Neutrophils; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Transcription, Genetic; Zymosan

2012